Fundraising FoxSV Health Investors — 2019 Investments
7 investments dated 2019 · listed companies and verified rows first · show all
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.
BiotechMedical Devices
Paul Yoo(Co-founder, President & Chief Scientific Officer)inSasha John(Co-founder and Chief Innovation Officer)inKeith R Carlton(Chief Executive Officer)in
Co-investorsGenesys CapitalToronto Innovation Acceleration Partners
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesAngelini VenturesDementia Discovery FundDolby Family VenturesMitsui Global Investment+2 more
BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.
Digital HealthHealthtechMedical DevicesSeattle, US
Gust H. Bardy(Executive Officer, Director, Promoter)Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)
Board seatPaul LaViolette· per SEC Form D
Co-investorsAPERTURE Venture PartnersAphelion CapitalAscension VenturesLumira VenturesRC CapitalRex Health Ventures+2 more
Ocular Therapeutix focuses on drug development and treatment for retinal diseases, with an emphasis on wet age-related macular degeneration and expanding into diabetic retinopathy conditions.
BiotechDigital HealthHealthtechMedical DevicesBedford, US
Amarpreet Sawhney(Director)Kevin Hanley(Executive Officer)Michael Goldstein(Executive Officer)inDaniel Bollag(Executive Officer)Antony Mattessich(Executive Officer, Director)inDonald Notman(Executive Officer)in
Board seatCharles Warden· per SEC Form D
Co-investorsAscension VenturesSofinnova VenturesTop Corner CapitalAgent Capital
Zerigo Health develops technology-driven digital therapeutics and care solutions for individuals living with chronic skin conditions.
Digital HealthHealthtechMedical Devices
Co-investors7wire VenturesCorewell Health VenturesGeneral CatalystH.I.G. CapitalH.I.G. HealthBridge PartnersAccel+3 more
.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
HealthifyMyOrthos
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.